Marianne Romeo
Corporate Officer/Principal bij MYOVANT SCIENCES LTD.
Actieve functies van Marianne Romeo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - | - |
| Bermuda Society For Healthcare Risk Management | Directeur/Bestuurslid | - | - |
Loopbaan van Marianne Romeo
Eerdere bekende functies van Marianne Romeo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | - | 01-04-2023 |
| Bowring Marsh (Bermuda) Ltd. | Algemeen Directeur | 01-01-2003 | 01-01-2014 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01-03-2014 | - |
| SIO GENE THERAPIES INC. | Directeur/Bestuurslid | 01-03-2015 | - |
| Corporate Officer/Principal | 01-03-2015 | - |
Opleiding van Marianne Romeo
| Tufts University | Undergraduate Degree |
| Hunter College | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Bermuda | 3 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Bermuda Society For Healthcare Risk Management | |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
| Bowring Marsh (Bermuda) Ltd. | |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Marianne Romeo
- Ervaring
